SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-23-049669
Filing Date
2023-06-16
Accepted
2023-06-16 16:27:02
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea180484-s3_enzobiochem.htm S-3 243203
2 OPINION OF MCDERMOTT WILL & EMERY LLP, COUNSEL TO THE REGISTRANT ea180484ex5-1_enzobiochem.htm EX-5.1 7582
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea180484ex23-1_enzobiochem.htm EX-23.1 2168
4 FILING FEE TABLE ea180484ex-fee_enzobiochem.htm EX-FILING FEES 15310
5 GRAPHIC image_001.jpg GRAPHIC 4149
6 GRAPHIC ex5-1_001.jpg GRAPHIC 14655
  Complete submission text file 0001213900-23-049669.txt   295401
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: S-3 | Act: 33 | File No.: 333-272727 | Film No.: 231021573
SIC: 8071 Services-Medical Laboratories